{"id":95126,"date":"2026-10-01T10:00:00","date_gmt":"2026-10-01T15:00:00","guid":{"rendered":"https:\/\/www.rxbriefcase.com\/rxbriefly-item\/%f0%9f%92%8a-should-pharmacists-trust-ai\/"},"modified":"2026-10-02T11:56:57","modified_gmt":"2026-10-02T16:56:57","slug":"%f0%9f%92%8a-should-pharmacists-trust-ai","status":"publish","type":"rxbriefly","link":"https:\/\/www.rxbriefcase.com\/fr\/rxbriefly-item\/%f0%9f%92%8a-should-pharmacists-trust-ai\/","title":{"rendered":"\ud83d\udc8a Should pharmacists trust AI?"},"content":{"rendered":"
\n
\n
\"\"<\/div>\n

Good morning dispensers of wisdom!<\/b><\/p>\n

\ud83d\udc89 GLP-1s may be shrinking more than appetites. A new study<\/a> of more than 2,000 children and teens taking GLP-1 drugs found that nearly 1 in 6 developed a nutritional deficiency or related complication within a year<\/b>, with vitamin D deficiency the most common. Yet fewer than a quarter had a nutrition counselling visit within 6 months of starting treatment. As GLP-1 use expands among younger patients, the findings raise a practical question: should nutrition monitoring become a bigger part of the GLP-1 conversation?<\/p>\n

Let\u2019s get into it.<\/p>\n

\n

RxBriefly is Now on Reddit \ud83d\udcac<\/h1>\n<\/div>\n
\n
\"\"<\/a><\/div>\n

We\u2019ve officially joined Reddit. r\/RxBriefly<\/b><\/a> is a new space for Canadian pharmacists to swap opinions, debate what\u2019s happening in pharmacy, answer polls, share the weird stuff that happens behind the counter and talk about the stories we cover here each week.<\/p>\n

We\u2019ve already got the conversation started. Come join us, weigh in and help us build a community for pharmacists who have a lot to say once the dispensary finally gets quiet.<\/p>\n

Join r\/RxBriefly <\/a><\/div>\n<\/div>\n
\n

Staying #Up2Date \ud83d\udea8<\/h1>\n<\/div>\n
\n
1: When AI Gets It Wrong <\/b><\/h5>\n

AI may make pharmacists more accurate, but there\u2019s a catch. In a new randomized simulation study<\/a>, 77 pharmacists and pharmacy trainees completed medication-order verification scenarios with or without AI assistance. Overall, AI improved accuracy, but when the AI recommendation was wrong, user accuracy plunged to 26.1%. Participants also accepted nearly three-quarters of incorrect AI recommendations, raising concerns about automation bias. The takeaway? AI may be a useful second set of eyes, but pharmacists still need to question what it tells them.<\/p>\n

2: The Prescribing Cascade<\/b><\/h5>\n

Sometimes the treatment for a new symptom is actually treating the side effect of another drug. A new Ontario-wide study<\/a> identified potentially inappropriate prescribing cascades among older adults, where a medication side effect is mistaken for a new condition and another drug is added to treat it. Researchers found common medications, including statins and iron supplements, among those potentially involved. For pharmacists reviewing a growing medication list, it\u2019s another reason to ask a deceptively simple question: did this symptom start after another medication did?<\/p>\n

3: 1 in 5 at Risk of a Drug Interaction<\/b><\/h5>\n

Polypharmacy isn’t getting any simpler. A new <\/a>JAMA<\/a><\/i> study<\/a> using nationally representative US data found that medication and supplement use among older adults has continued to rise. While potentially major drug-drug interactions declined somewhat compared with earlier years, more than 1 in 5 older adults remained potentially at risk. The study included prescription drugs, OTC medications and dietary supplements, making the findings particularly relevant at the pharmacy counter, where the medication list patients provide may not tell the whole story.<\/p>\n<\/div>\n

\n

Shelf Watch \ud83c\udfe5<\/h1>\n<\/div>\n
\n

Drug Shortages<\/b> \u26a0\ufe0f<\/p>\n

Vitamin B12\u00a0<\/b><\/a><\/p>\n